HUP0202767A3 - Ascididemin derivatives, process for their preparation and pharmaceutical compositions containing them - Google Patents
Ascididemin derivatives, process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- HUP0202767A3 HUP0202767A3 HU0202767A HUP0202767A HUP0202767A3 HU P0202767 A3 HUP0202767 A3 HU P0202767A3 HU 0202767 A HU0202767 A HU 0202767A HU P0202767 A HUP0202767 A HU P0202767A HU P0202767 A3 HUP0202767 A3 HU P0202767A3
- Authority
- HU
- Hungary
- Prior art keywords
- ascididemin
- derivatives
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- BTAIBIXHXSXUFN-UHFFFAOYSA-N ascididemine Chemical class C1=CC=CC2=NC(C(=O)C=3C4=NC=CC=3)=C3C4=NC=CC3=C21 BTAIBIXHXSXUFN-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9910490A FR2797445B1 (fr) | 1999-08-13 | 1999-08-13 | Derives d'ascididemine et leurs applications therapeutiques |
| FR0006652A FR2809399B1 (fr) | 2000-05-24 | 2000-05-24 | Nouveaux derives d'ascididemine et leurs applications therapeutiques |
| PCT/FR2000/002312 WO2001012631A2 (fr) | 1999-08-13 | 2000-08-11 | Derives d'ascididemine et leurs applications therapeutiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0202767A2 HUP0202767A2 (hu) | 2003-01-28 |
| HUP0202767A3 true HUP0202767A3 (en) | 2003-12-29 |
Family
ID=26212422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0202767A HUP0202767A3 (en) | 1999-08-13 | 2000-08-11 | Ascididemin derivatives, process for their preparation and pharmaceutical compositions containing them |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1202992B1 (hu) |
| JP (1) | JP2003507381A (hu) |
| CN (1) | CN1195754C (hu) |
| AT (1) | ATE276256T1 (hu) |
| AU (1) | AU779932B2 (hu) |
| BR (1) | BR0013249A (hu) |
| CA (1) | CA2393965A1 (hu) |
| CZ (1) | CZ2002528A3 (hu) |
| DE (1) | DE60013849T2 (hu) |
| DK (1) | DK1202992T3 (hu) |
| ES (1) | ES2228602T3 (hu) |
| HU (1) | HUP0202767A3 (hu) |
| IL (1) | IL147900A0 (hu) |
| MX (1) | MXPA02001512A (hu) |
| NO (1) | NO20020668L (hu) |
| NZ (1) | NZ516896A (hu) |
| PL (1) | PL353453A1 (hu) |
| PT (1) | PT1202992E (hu) |
| SK (1) | SK1662002A3 (hu) |
| WO (1) | WO2001012631A2 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3548486B1 (de) * | 2016-12-05 | 2021-10-27 | Merck Patent GmbH | Materialien für organische elektrolumineszenzvorrichtungen |
-
2000
- 2000-08-11 CA CA002393965A patent/CA2393965A1/fr not_active Abandoned
- 2000-08-11 DE DE60013849T patent/DE60013849T2/de not_active Expired - Fee Related
- 2000-08-11 BR BR0013249-7A patent/BR0013249A/pt not_active IP Right Cessation
- 2000-08-11 PT PT00958678T patent/PT1202992E/pt unknown
- 2000-08-11 IL IL14790000A patent/IL147900A0/xx unknown
- 2000-08-11 PL PL00353453A patent/PL353453A1/xx not_active Application Discontinuation
- 2000-08-11 NZ NZ516896A patent/NZ516896A/en unknown
- 2000-08-11 CZ CZ2002528A patent/CZ2002528A3/cs unknown
- 2000-08-11 JP JP2001517529A patent/JP2003507381A/ja active Pending
- 2000-08-11 WO PCT/FR2000/002312 patent/WO2001012631A2/fr active IP Right Grant
- 2000-08-11 AT AT00958678T patent/ATE276256T1/de not_active IP Right Cessation
- 2000-08-11 DK DK00958678T patent/DK1202992T3/da active
- 2000-08-11 EP EP00958678A patent/EP1202992B1/fr not_active Expired - Lifetime
- 2000-08-11 SK SK166-2002A patent/SK1662002A3/sk unknown
- 2000-08-11 MX MXPA02001512A patent/MXPA02001512A/es unknown
- 2000-08-11 ES ES00958678T patent/ES2228602T3/es not_active Expired - Lifetime
- 2000-08-11 AU AU70124/00A patent/AU779932B2/en not_active Ceased
- 2000-08-11 CN CNB008126569A patent/CN1195754C/zh not_active Expired - Fee Related
- 2000-08-11 HU HU0202767A patent/HUP0202767A3/hu unknown
-
2002
- 2002-02-11 NO NO20020668A patent/NO20020668L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1202992A2 (fr) | 2002-05-08 |
| PL353453A1 (en) | 2003-11-17 |
| DE60013849D1 (de) | 2004-10-21 |
| JP2003507381A (ja) | 2003-02-25 |
| HUP0202767A2 (hu) | 2003-01-28 |
| NO20020668L (no) | 2002-04-15 |
| DE60013849T2 (de) | 2005-02-03 |
| SK1662002A3 (en) | 2002-09-10 |
| CZ2002528A3 (cs) | 2002-05-15 |
| CA2393965A1 (fr) | 2001-02-22 |
| MXPA02001512A (es) | 2002-07-02 |
| WO2001012631A2 (fr) | 2001-02-22 |
| NO20020668D0 (no) | 2002-02-11 |
| AU779932B2 (en) | 2005-02-17 |
| EP1202992B1 (fr) | 2004-09-15 |
| CN1373762A (zh) | 2002-10-09 |
| AU7012400A (en) | 2001-03-13 |
| WO2001012631A3 (fr) | 2001-07-19 |
| ATE276256T1 (de) | 2004-10-15 |
| BR0013249A (pt) | 2002-04-16 |
| CN1195754C (zh) | 2005-04-06 |
| DK1202992T3 (da) | 2005-01-24 |
| IL147900A0 (en) | 2002-08-14 |
| ES2228602T3 (es) | 2005-04-16 |
| NZ516896A (en) | 2004-02-27 |
| PT1202992E (pt) | 2004-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0203316A3 (en) | Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0300618A3 (en) | Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP0204245A3 (en) | Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0203548A3 (en) | New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0204515A3 (en) | 4-aminopiperidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0203294A3 (en) | Benzodiazepine derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0000748A3 (en) | 4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0201516A2 (en) | 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0105114A3 (en) | Quinazolinone derivatives, pharmaceutical compositions containing them, their use and process for their preparation | |
| HUP0201753A3 (en) | Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0203052A3 (en) | Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
| HUP0203184A3 (en) | Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0202075A3 (en) | Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0203140A3 (en) | Bicyclic imidazo-5-yl-amine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0201402A3 (en) | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them | |
| HUP0203385A3 (en) | Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0202731A3 (en) | O-anisamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0201315A3 (en) | 4-phenyl-pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP0105479A3 (en) | Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0204001A3 (en) | Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0303361A3 (en) | Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0101234A3 (en) | Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof | |
| HUP0201797A3 (en) | 3-amino-2-benzyl-1-phenyl-propane derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0203859A3 (en) | Aminomethyl-phenyl-cyclohexanone derivatives, process for their preparation, pharmaceutical compositions containing them and their use |